Experimental lung cancer vaccine lands Berkeley company potential $817M deal

Tiny Aduro BioTech Inc.’s experimental cancer vaccine has come up big again, landing a potential $817 million deal with Johnson & Johnson’s Janssen Biotech unit around lung cancer, the companies said Thursday...